BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18246821)

  • 1. [Establishment and application of a murine transplant model of bone marrow purging of metastatic breast cancer cells in vitro].
    Hu ZP; Liu WL; Stuart B; Zhang YC
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):621-3. PubMed ID: 18246821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
    Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
    Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.
    Huang HF; Chen YZ; Wu Y; Chen P
    Bone Marrow Transplant; 2006 Jan; 37(2):213-7. PubMed ID: 16284611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
    Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
    Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine.
    Schneiderman MH; Jackson JD; Joshi SS; Clark-Pierce L; Murphy BJ; Schneiderman GS
    Radiat Res; 1998 Feb; 149(2):147-54. PubMed ID: 9457894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
    Frondoza CG; Sinha S; Trivedi SM; Humphrey RL; Colvin OM
    Exp Hematol; 1987 Jul; 15(6):715-8. PubMed ID: 3297761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ; Colvin OM; Sensenbrenner LL
    Cancer Res; 1988 Jun; 48(12):3394-7. PubMed ID: 3285994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
    Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
    Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation.
    Wu A; Mazumder A; Martuza RL; Liu X; Thein M; Meehan KR; Rabkin SD
    Cancer Res; 2001 Apr; 61(7):3009-15. PubMed ID: 11306480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel HSV-1 virus, JS1/34.5-/47-, purges contaminating breast cancer cells from bone marrow.
    Hu JC; Booth MJ; Tripuraneni G; Davies D; Zaidi SA; Tamburo de Bella M; Slade MJ; Marley SB; Gordon MY; Coffin RS; Coombes RC; Kamalati T
    Clin Cancer Res; 2006 Nov; 12(22):6853-62. PubMed ID: 17121907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purging breast cancer cells in preparation for autologous bone marrow transplantation.
    Morecki S; Pavlotzky F; Margel S; Slavin S
    Bone Marrow Transplant; 1987 Apr; 1(4):357-63. PubMed ID: 3332143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123.
    Wong JR; Ho C; Mauch P; Coleman N; Berman S; Chen LB
    Clin Cancer Res; 1995 Jun; 1(6):621-30. PubMed ID: 9816024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
    Jiang R; Han M; Zhao Y
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
    Weiss L; Slavin G; Reich S; Sidi H; Slavin S
    Bone Marrow Transplant; 1994 Jan; 13(1):27-30. PubMed ID: 8019450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dye-mediated photosensitization of murine neuroblastoma cells.
    Sieber F; Sieber-Blum M
    Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexaminolevulinate-mediated photodynamic purging of marrow grafts with murine breast carcinoma.
    Čunderlíková B; Vasovič V; Sieber F; Furre T; Borgen E; Nesland JM; Peng Q
    Bone Marrow Transplant; 2011 Aug; 46(8):1118-27. PubMed ID: 21057550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice through serial passage in vivo].
    Yang M; Yang ZH; Hou ZD; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):944-7. PubMed ID: 18583234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanine arabinoside as a bone marrow-purging agent.
    Kurtzberg J
    Ann N Y Acad Sci; 1993 Jun; 685():225-36. PubMed ID: 8363226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.